The hypoxia-induced microRNA-130a controls pulmonary smooth muscle cell proliferation by directly targeting CDKN1A

Area of Science:

• Molecular Biology
• Cardiovascular Research
• Cell Biology

Background:

• Pulmonary hypertension involves vascular remodeling driven by excessive smooth muscle cell proliferation.
• Hypoxia is known to inhibit the tumor suppressor p21 (CDKN1A), but the underlying mechanism remains unclear.

Purpose of the Study:

• To elucidate the mechanism by which hypoxia affects CDKN1A expression.
• To investigate the role of microRNAs (miRNAs) in regulating CDKN1A in hypoxia-induced pulmonary hypertension.

Main Methods:

• Utilized a mouse model of hypoxia-induced pulmonary hypertension and in vitro experiments with human pulmonary artery smooth muscle cells (HPASMC).
• Assessed the impact of miRNAs on CDKN1A expression using transfection, anti-miRs, seed blockers, and reporter gene assays.
• Analyzed miR-130 expression and CDKN1A levels under hypoxic conditions and in response to miR-130 inhibition.

Main Results:

• Identified the miR-130 family as a regulator of CDKN1A expression.
• miR-130 transfection decreased CDKN1A and increased HPASMC proliferation; miR-130 inhibition increased CDKN1A.
• Reporter gene assays confirmed a direct interaction between miR-130 and CDKN1A.
• Hypoxia induced miR-130 expression, leading to decreased CDKN1A in HPASMC and in the mouse model.
• Inhibition of miR-130 in mice restored CDKN1A expression.

Conclusions:

• The miR-130 family plays a critical role in repressing CDKN1A under hypoxic conditions.
• miR-130 promotes hypoxia-induced smooth muscle cell proliferation.
• miR-130 may contribute to vascular remodeling and right ventricular hypertrophy in pulmonary hypertension.